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1. Introduction  
   Definitive erythropoiesis arises in mouse fetal liver around embryonic day (E) 10 onward and 
subsequently switches to postnatal bone marrow and spleen, in which enucleated red blood cells 
emerge.1 During terminal erythroid differentiation, erythroblasts are associated with a central 
macrophage, which forms a specialized microenvironment, the so-called erythroblastic islands. In 
the erythroblastic islands, a central macrophage provides favorable proliferative and survival 
signals to the surrounding erythroblasts, and it eventually engulfs the extruded nuclei of maturing 
erythrocytes.2-6 Inhibition of the interaction between macrophage and erythroblasts usually leads to 
embryonic anemia accompanied by accelerated apoptosis of erythroid cells. Targeted disruption of 
either the transcription factor Rb (retinoblastoma) or actin cytoskeleton associated protein palld 
(palladin) prevented effective erythroblast-macrophage interactions due to differentiation defects in 
the macrophage. Therefore, mouse embryos homozygous for either mutant gene suffer from severe 
anemia and succumb in the embryonic period.7,8 Meanwhile, it has been reported that a series of 
adhesion molecules are also involved in the process of forming erythroblastic islands. Erythroblast 
macrophage protein (EMP) is a 33~36 kDa transmembrane protein expressed in both erythroblasts 
and macrophages, and it mediates the erythroblast-macrophage interaction. Indeed, the targeted 
deletion of EMP causes lethal anemia in mouse embryos due to the suppressed formation of 
erythroblastic islands.9 Furthermore, a previous report demonstrated that the interaction between 
very late antigen-4 (α4β1 integrin) on erythroblasts and vascular cell adhesion molecule 1 
(VCAM-1) on macrophages plays a key role in maintaining the islands.10 For example, 
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administration of antibodies raised against either α4β1 integrin or VCAM-1 caused disruption of the 
island structure and the resultant erythropoietic deficiency10. However, the molecular mechanism, in 
terms of transcriptional regulation of island-affiliated genes in macrophages, remains largely 
unknown. 
   The large Maf transcription factor c-Maf is a cellular homolog of v-maf, which was isolated 
from a chicken musculoaponeurotic fibrosarcoma induced by avian retrovirus AS42 infection.11 The 
large Maf transcripton factors, i.e., MafA/L-Maf/SMaf, MafB, c-Maf and NRL, contain an acidic 
domain that promotes transcriptional regulation and a basic region/leucine zipper domain that 
mediates dimerization, as well as DNA binding to either Maf recognition elements (MAREs) or the 
5′ AT-rich half-MARE.12-14 Each large Maf protein has been shown to play a distinct role in cellular 
proliferation and differentiation in both pathological and physiological situations.11,15-21 In 
B-lymphoid and T-lymphoid lineages, aberrant expression of c-Maf works as an oncogene, as 
shown in multiple myeloma and angioimmunoblastic T-cell lymphoma (AITL) patients and in a 
transgenic mouse model.22-25 Physiological c-Maf expression is indispensable for the proper 
regulation of interleukin (IL)-4 and IL-21 gene expression in T-helper cells.26,27 In macrophages, 
c-Maf has been reported to regulate IL-10 expression, which is essential for differentiation of 
regulatory T-cells.28 In addition, combined deficiency of MafB and c-Maf enables long-term 
expansion of differentiated, mature macrophages.29 We recently reported that c-Maf is abundantly 
expressed in fetal liver macrophages and that it regulates expression of F4/80, which mediates 
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immune tolerance.30 However, the physiological consequences of c-Maf deletion on terminal 
erythroid differentiation in erythroblastic islands have been largely unexplored.  
   In the present study, we demonstrate that c-Maf-deficient mice exhibit embryonic anemia, 
which is associated with a failure to form erythroblastic islands. Moreover, we found significantly 
reduced expression of VCAM-1 in c-Maf-deficient macrophages, which presumably accounts for 
the deficiency in island formation and subsequent embryonic anemia. Thus, these results suggest 
that c-Maf is indispensable for definitive erythropoiesis in fetal liver, as it activates VCAM-1 
expression in macrophages, and this causes the formation of erythroblastic islands.  
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2. Material and methods 
2-1. Mice 
   c-Maf deficient mice were originally generated on a 129/Sv background16 and have been 
backcrossed onto a C57BL/6J background for more than seven generations. Genotypes were 
determined by PCR analysis using tail DNA. In staging the embryos, gestational day 0.5 (E0.5) was 
defined as noon of the day a vaginal plug was found following overnight mating. Mice were 
maintained in specific pathogen-free conditions in a Laboratory Animal Resource Center. All 
experiments were performed according to the Guide for the Care and Use of Laboratory Animals at 
the University of Tsukuba.  
 
2-2. Hematologic analysis of fetal liver cells, embryonic blood and adult blood 
   Single-cell suspensions prepared from fetal livers were washed by centrifugation at 1,000 rpm 
for 5 minutes at 4°C and resuspended in 1 ml of 2% fetal bovine serum/phosphate-buffered saline 
(PBS). The cell number was counted using a hemocytometer. Collection of embryonic peripheral 
blood was performed as described previously.31 In brief, the embryo was dried with the tip of a 
Kimwipe (Kimberly-Clark, Dallas, TX). Blood was collected with a Microcaps micropipette 
(Drummond Scientific, Broomal, PA) from the carotid arteries of decapitated embryos. Each sample 
was centrifuged at 12,000 g for 5 minutes for hematocrit measurement on Hematocrit Centrifuge 
3220 (Kubota, Tokyo, Japan). Peripheral blood samples from adult mice were obtained from 
retro-orbital venous plexus using heparin-coated microtubes. Blood counts were determined with an 
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automated hemocytometer (Nihon Kohden, Tokyo, Japan). Blood smears were prepared using the 
wedge technique and were stained with May-Grünwald Giemsa, and then photographed with a 
KEYENCE BIOREVO BZ-9000 microscope (KEYENCE, OSAKA, Japan). Images were 
processed using Photoshop software (Adobe, San Jose, CA). 
 
2-3. Flow cytometry and Cell cycle analysis 
   Freshly isolated fetal liver cells were immunostained at 4°C in PBS/2%FBS in the presence of 
5% mouse serum to block Fc receptors. Cells were incubated with fluorescein isothiocyanate  
(FITC)-conjugated anti-mouse CD71 (eBioscience, San Diege, CA) and allophycocyanin 
(APC)-conjugated anti-mouse TER-119 (eBioscience) antibodies for 30 minutes at 4°C, followed 
by a 5-minute incubation with phycoerythrin (PE)-conjugated Annexin V (BioVision, Mountain 
View, CA) at room temperature. To quantify the presence of VCAM-1 on macrophages, 
FITC-conjugated anti-mouse Mac-1 (CD11b), biotinylated anti-mouse VCAM-1 and 
APC-conjugated streptavidin antibodies were used for analyses. For cell cycle analysis, single cell 
suspensions of E12.5 fetal liver cells were suspended in 4 ml ice-cold 70% ethanol with gentle 
vortexing, incubated at -20°C for 4 hours, and washed with PBS. Cells were then incubated with 
0.2mg/ml RNase (Invitrogen) / PBS at 37°C for 60 minutes. Propidium iodide (PI) was added at a 
final concentration of 50µg/ml. Flow cytometry was carried out on a Becton Dickinson FACS LSR 
with CELLQuest (Becton Dickinson) software. Data were analyzed using FlowJo (Tree Star Inc., 
Ashland, OR) analysis software.  
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2-4. Histology and TUNEL assay 
   Whole E13.5 embryos were fixed in 10% formalin neutral buffer solution (Wako, Japan) 
Paraffin-embedded tissue was sectioned, mounted, and stained with hematoxylin and eosin. 
Fluorescent terminal dUTP nick-end labeling (TUNEL) assays were performed using an in situ 
Apoptosis Detection Kit according to the manufacturer’s protocol (TaKaRa, Tokyo, Japan). Images 
were captured by a digital camera system using a Leica DM RXA2 microscope (Leica 
Microsystems, Tokyo, Japan).  
 
2-5. Colony-forming unit assay 
   Colony-forming unit assays were performed in MethoCult GF M3434 (Stem Cell Technologies) 
for BFU-E and CFU-GEMM, and M3334 for CFU-E following the manufacturers’ instructions. 
CFU-E were scored two days after plating. BFU-E and CFU-GEMM were scored eight days after 
plating on coded plates for unbiased counts.  
 
2-6. Reconstitution of hematopoietic system with fetal liver cells  
   The donor cells for hematopoietic reconstitution were prepared from E14.5 fetal livers of  
c-Maf+/+ and c-Maf-/- (C57BL/6J-Ly5.1) mice. Suspensions of single fetal liver cells were prepared 
by mechanical disruption, grinding with a syringe insert against a 70 µm nylon cell strainer 
(BD-Biosciences, San Jose, CA). Fetal liver cells (2 × 106 cells) were injected into the tail vein of 8- 
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to 10-week-old C57BL/6J-Ly5.2 mice that were previously exposed to X-ray at the doses of 10 Gy.  
 
2-7. Preparation of “Native” erythroblastic islands and “Reconstituted” erythroblastic islands 
   Native erythroblastic islands were isolated from fetal livers using a previously described 
protocol.7 Briefly, E13.5 fetal livers were dissected and dispersed by enzymatic digestion with 
collagenase S-1 (Nitta Gelatin, Osaka, Japan) and DNase I (Sigma-Aldrich, St. Louis, MO). 
Digested fetal liver cells were allowed to attach to glass coverslips for 20 minutes at 37°C in 5% 
CO2. Attached cells were then flooded with medium and incubated for 4 hours. Adherent 
macrophages with attached erythroid clusters were obtained by dipping coverslips in RPMI to 
remove nonadherent cells and were then processed for immunofluorescence analysis. To strip 
erythroblasts from macrophages, cells were incubated in PBS lacking Ca2+ and Mg2+ for 10 minutes. 
The remaining adherent fetal liver cells were allowed to re-spread in RPMI containing 10% FBS for 
2 hours before receiving fresh erythroblasts (c-Maf+/+ or c-Maf-/- E14.5 erythroblasts). Finally, the 
reconstituted clusters were dipped to remove the unbound cells before being processed for double 
F4/80-Ter119 immunofluorescence using standard procedures. The number of erythroblasts 
attached to macrophages was determined by counting the total number of cells present in each 
island visualized using a Leica fluorescence microscope. Four to six embryos were analyzed per 
combination group. For each combination, at least 20 macrophages per embryo were analyzed.  
 
2-8. Microarray analysis of fetal liver macrophages 
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   Fetal liver cells from E15.5 c-Maf+/+ and c-Maf-/- embryos were incubated with APC-conjugated 
anti-Mac-1 antibody (eBioscience) and PE-conjugated anti-F4/80 antibody (Serotec). Mac-1+F4/80+ 
cells were sorted by a FACSAria cell sorter (Becton Dickinson) as fetal liver macrophages. Total 
RNA was extracted from fetal liver macrophages using a QIAGEN RNeasy Mini Kit according to 
the manufacturer’s instructions. The microarray procedure was performed as described in the 
Affymetrix GeneChip Expression Analysis Manual (Affymetrix). Biotin-labeled cRNA was 
synthesized from 4 to 6 µg RNA and hybridized to a GeneChip Mouse Genome 430 2.0 Array 
(Affymetrix). After washing, arrays were stained with streptavidin-phycoethrin and analysed on a 
scanner. Each array was analyzed using the GeneSpring (Agilent Technologies, Palo Alto, CA) 
program to calculate the average density for each prove set (Affymetrix). Data normalization and 
data analyses were performed using GeneSpring. The data have been deposited in the Gene 
Expression Omnibus database under the accession number GSE23305. 
 
2-9. Real time RT-PCR analysis of fetal liver macrophages 
   Macrophages were prepared from E13.5 and E14.5 fetal livers of c-Maf+/+ or c-Maf-/- mice. 
Suspensions of single fetal liver cells were prepared and Mac-1 positive cells were labeled with 
Mac-1+ magnetic beads to separate macrophages by using the MACSTM system (Miltenyi Biotech). 
Total RNA was extracted from cells using RNeasy Mini Kit (QIAGEN), and first-strand cDNA was 
synthesized using QuantiTect Rev. Transcription Kit (QIAGEN). The mRNA levels were examined 
by real time RT-PCR using Thermal Cycler Dice Real Time System Single (TaKaRa Bio) with a 
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SYBR Green PCR master mix (TaKaRa Bio). Hypoxanthine guanine phosphoribosyl transferase 
(Hprt) was used as an internal control. The following specific primers were used for PCR: 
VCAM-1-forward; 5’-GGATGAACACTCTTACCTGTGC, VCAM-1-reverse; 
5’-GGTCAAAGGGATACACATTAGGG, EMP-forward; 5’- CCACCAGACACACATATCTC, . 
EMP-reverse; 5’-CTGCACACAGGGCAGTCAGG, Other primers were as reported 
previously.30,32,33  
 
2-10. Luciferase reporter assay 
   The VCAM-1 (-0.7 kilobase (kb)) promoter ligated to a luciferase reporter34 was transiently 
co-transfected with c-Maf expression plasmids in macrophage cell line RAW264.7 using Fugene 6 
(Roche). Twenty-four hours after the transfection, cells were collected and reporter gene assays 
were carried out using the Dual Luciferase Kit (Promega, Madison,WI). Transfection efficiency was 
normalized by measuring expression of Renilla Luciferase.  
 
2-11. Statistical analysis 
   Data were represented as mean plus and minus a standard error of the mean (SEM). Statistical 
significance between any two groups was determined by the 2-tailed Student t test. p values less 
than 0.05 were considered significant.  
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3. Results 
3-1. Lethal erythropoietic deficiency in c-Maf-/- embryo. 
   The c-Maf-/- mice, as originally generated, exhibited perinatal mortality within a few hours after 
birth on a 129/Sv background.16 However, unexpectedly, on a C57BL/6J genetic background, 
c-Maf-deficiency resulted in embryonic lethality from E15.5 onward, and almost all c-Maf-/- 
embryos died before E18.5 (Table 1). c-Maf-/- embryos at E13.5 showed appearance of a pale fetal 
liver as well as thin yolk sac blood vessels, in which fewer red blood cells were circulating, 
compared with healthy c-Maf+/+ control embryos (Figure 1A). As expected, the hematocrit of 
peripheral blood in the c-Maf-/- embryo (E13.5~E15.5) was markedly reduced (E13.5: 13.4±1.8%, 
E14.5: 14.5±1.0%, E15.5: 16.9±1.0%), compared with the c-Maf+/+ control (E13.5: 18.7±0.6%, 
E14.5: 23.1±1.7%, E15.5: 29.6±1.8%; Figure 1B). May-Grünwald Giemsa staining of peripheral 
blood smears demonstrated a significant reduction of enucleated red blood cells in c-Maf-/- embryos 
(E13.5: 6.68±1.0%, E14.5: 17.2±1.9%, E15.5: 29.8±5.6%; Figure 1C and D), whereas c-Maf+/+ 
control embryos retained normal population of enucleated red blood cells (E13.5: 25.5±4.7%, 
E14.5: 54.1±1.1%, E15.5: 86.9±2.8%; Figure 1C-D). Considering that the enucleated red blood 
cells are mainly derived from definitive erythropoiesis, these data suggest that c-Maf-deficient 
embryos suffer from impaired definitive erythropoiesis on the C57BL/6J genetic background.  
 
3-2. Increased apoptotic cell death in c-Maf-/- fetal liver 
   We next examined the cellular viability as well as the cell cycle status of c-Maf-/- fetal liver cells, 
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in the hope of elucidating the molecular and cellular basis of their erythropoietic deficiency. The 
fetal liver size in c-Maf-/- embryos was smaller, thus consistently fewer number of fetal liver cells 
were harvested from c-Maf-/- embryos between E13.5 and E15.5 (E13.5: 3.37±0.5 ×106 cells, E14.5: 
7.61±1.0 ×106 cells, E15.5: 6.54±2.7 ×106 cells) than from age-matched c-Maf+/+ control embryos 
(E13.5: 6.89±0.4 ×106 cells, E14.5: 16.6±2.3 ×106 cells, E15.5: 32.5±2.4 ×106 cells) (Figure 2A-B). 
Of note, hematoxylin-eosin (HE) staining of E13.5 c-Maf-/- fetal liver sections demonstrated an 
increased number of pyknotic nuclei compared to the c-Maf+/- control embryo (Figure 2C). 
Consistently, TUNEL-positive apoptotic cells were remarkably increased in E13.5 c-Maf-/- fetal 
liver sections (Figure 2C). Moreover, flow cytometry analysis of PI-stained fetal liver cells 
demonstrated an increased abundance of a sub-G0/G1 early apoptotic cell fraction in c-Maf-/- fetal 
liver (8.77±2.5%) compared with c-Maf+/+ control cells (0.67±0.01%; Figure 2D). However, the 
cellular population of each phase of the cell cycle, i.e., G0/G1, S and G2/M, was not significantly 
affected (Figure 2D). Overall, these observations suggest that the fetal liver hematopoietic cells 
from c-Maf-/- embryos are prone to undergo apoptotic cell death.  
 
3-3. Impaired fetal liver erythropoiesis due to a non-cell-autonomous effect of 
c-Maf-deficiency 
   Given the significant disturbance of erythropoiesis, we next attempted to delineate the 
maturation status of erythroid lineage cells in c-Maf-/- fetal liver. To this end, we examined fetal 
liver erythropoiesis by flow cytometry using the erythroid markers CD71 and Ter119, which 
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distinguish various stages of erythroid-cell differentiation. In the early stages of Ter119low erythroid 
progenitor development, CD71 expression increases toward the stage of erythroid commitment. 
However, once they differentiate into Ter119high erythroblasts, CD71 expression decreases during 
terminal erythroblast maturation.35 Interestingly, in c-Maf-/- fetal liver, the percentages of Ter119high 
differentiating erythroblasts (R3, R4 and R5 in Figure 3A) were reduced, whereas the percentages 
of cells in early stages of erythroid progenitors (R1 and R2 in Figure 3A) were increased compared 
with c-Maf+/+ fetal liver. Similarly decreased numbers of mature erythroid cells (R3, R4 and R5 in 
Figure 3B) were observed in c-Maf-/- fetal liver as compared with c-Maf+/+ fetal liver. Consistent 
with this flow cytometry data, morphological observations of cytospined fetal liver erythroid cells 
demonstrated that the number of later stage erythroblasts (late basophilic, polychromatophilic and 
orthochromatophilic erythroblasts) was significantly reduced in c-Maf-/- embryos as compared with 
c-Maf+/+ controls (Figure 3D). These observations prompted us to quantify the apoptotic cell 
population in each stage of erythroid cells by annexin V staining in combination with Ter119 and 
CD71 staining.  
   In good agreement with the preferential decrease of the late erythroblast population (R3, R4 and 
R5), we observed a highly increased number of annexin V-positive cells in the more mature 
erythroblasts (R4 and R5) of c-Maf-/- fetal liver as compared with the c-Maf+/+ fetal liver. In contrast, 
the premature erythroid progenitors (R1, R2 and R3) of c-Maf-/- fetal liver cells exhibited a 
comparable number of annexin V-positive cells with the c-Maf+/+ control (Figure 3C). To examine 
the state of globin regulation, the Mac-1 negative cells from E13.5 fetal liver were sorted by 
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MACSTM and analyzed for mRNA of β-globin genes by real time RT-PCR analysis. Expression 
profiles showing switching of β-globin genes demonstrated that the definitive globin gene 
(βmajor-globin) was significantly down-regulated, while the primitive globin genes (βH1-globin 
and εy-globin) were not significantly suppressed in the c-Maf-/- fetal liver erythroid fraction 
compared with the c-Maf+/+ control (Figure 4).  
   To examine the colony formation potential of hematopoietic progenitors in c-Maf-/- fetal liver, 
conventional set of colony-forming unit (CFU) assays were performed. Eventually we found that 
there was no significant difference in the number of Burst-Forming Unit-Erythroid (BFU-E) or 
Colony-Forming Unit-Granulocyte, Erythroid, Macrophage, Megakaryocyte (CFU-GEMM) 
between c-Maf+/+ and c-Maf-/- fetal liver cells (Figure 3E). However, the Colony-Forming 
Unit-Erythroid (CFU-E) count was increased about two-fold in c-Maf-/- fetal liver cells compared 
with c-Maf+/+ fetal liver. Moreover, erythroid cells derived from c-Maf-/- CFU-Es exhibited a similar 
morphology and an equivalent number of enucleated red blood cells as those from c-Maf+/+ control 
CFU-Es, in cytospin slides stained with May-Grünwald Giemsa (Figure 5A-B). Taken together, 
these results suggest that c-Maf-/- erythroid cells are still capable of differentiating into mature red 
blood cells, therefore the impaired definitive erythropoiesis in the c-Maf-/- embryos is more likely 
due to a non-cell-autonomous effect of c-Maf-deficiency.  
 
3-4. c-Maf-deficient fetal liver cells are capable of reconstituting the hematopoietic system of 
adult mice 
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   To determine whether c-Maf-/- embryos still retain hematopoietic stem cells, we tested the ability 
of c-Maf-deficient fetal liver cells to reconstitute the hematopoietic system of lethally irradiated 
recipient mice. Fetal liver cells collected from E14.5 c-Maf+/+ or c-Maf-/- embryos were injected into 
lethally irradiated recipient mice. All recipients receiving both c-Maf+/+ and c-Maf-/- fetal liver cells 
survived and remained healthy for at least 6 months after transplantation. Consistent with the results 
obtained from CFU assays, the donor-derived leukocyte chimerism in the mice reconstituted with 
c-Maf-/- fetal liver cells was comparable with that of the recipient mice with control fetal liver cells 
(Figure 6A). Moreover, there were no significant differences in hematocrit or proportion (%) of 
B220+, CD4+, CD8+, or Mac+/Gr1+ cells between the recipients receiving c-Maf+/+ or c-Maf-/- fetal 
liver cells (Table 2 and Figure 6B).  
   Next, we tried to examine whether erythroblast differentiation in bone marrow and spleen was 
perturbed. Each stage of the erythroblasts was prospectively separated by a similar flow cytometry 
protocol using TER-119 and CD71 antibodies, i.e., TER-119+/CD71+ cells consisting of immature 
erythroblasts, whereas TER-119+/CD71- cells corresponded to mature erythroblasts. The 
percentages of TER-119-/CD71+ cells, TER-119+/CD71+ cells and TER-119+/CD71- cells in the 
recipient bone marrow receiving c-Maf-/- fetal liver cells were comparable to those in the recipient 
with c-Maf+/+ fetal liver cells (Figure 6C). Similar results were also observed using spleen cells 
(Figure 6D). Overall, these results indicate that c-Maf-/- hematopoietic cells are able to reconstitute 
the hematopoietic system in lethally irradiated mice, and that they have the ability to produce 
adequate amounts of erythroid cells.  
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3-5. Absence of c-Maf causes impaired erythroblastic island formation in the fetal liver.  
   c-Maf is abundantly expressed in fetal liver macrophages, although it is largely missing from 
the erythroid cells in fetal liver. Therefore, we initially surmised that c-Maf-deficiency in fetal liver 
macrophages disturbed the proper formation of erythroblastic islands4, then subsequently led to 
embryonic anemia. To address this hypothesis, we tried to examine whether c-Maf-/- macrophages 
failed to form erythroblastic islands. For this purpose, we isolated the erythroblastic island from 
c-Maf+/+ and c-Maf-/- fetal livers and counted the number of erythroblasts associated with each 
single central macrophage according to a previously described method.7  
   Interestingly, although more than ten Ter119-positive erythroblasts were adhered to a F4/80 
positive macrophage in c-Maf+/+ fetal livers, c-Maf-deficient central macrophages seemed to harbor 
far fewer erythroblasts (Figure 7). As shown in Figure 7A, the number of erythroblasts attached to a 
single central macrophage was significantly reduced in c-Maf-/- erythroblastic islands (14.2±0.3 and 
5.6±1.5 erythroblasts per macrophage for c-Maf+/+ and c-Maf-/-, respectively). This result clearly 
indicates that erythroblastic island formation is impaired in the c-Maf-/- fetal livers.  
   Next, to address whether c-Maf-deficiency in macrophages was particularly responsible for the 
impairment of erythroblastic island formation, we performed a series of reconstitution experiments. 
After attaching the native erythroblastic island either from c-Maf+/+ or c-Maf-/- fetal livers on a glass 
coverslip, the adherent erythroblasts in islands were stripped from macrophages. Then, the freshly 
isolated erythroblasts from c-Maf+/+ or c-Maf-/- fetal livers were co-cultured on the remaining 
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adherent c-Maf+/+ or c-Maf-/- fetal liver macrophages, respectively, so that c-Maf+/+ erythroblast 
were co-cultured on c-Maf-/- central macrophages and vice versa. Surprisingly, c-Maf-/- macrophages 
failed to support erythroblastic island formation with the inoculated wild-type erythroblasts 
(12.7±0.5 erythroblasts per c-Maf+/+ macrophage and 4.8±0.2 erythroblasts per c-Maf-/- macrophage; 
Figure 7B). In contrast, c-Maf-/- erythroblasts were still capable of attaching to c-Maf+/+ 
macrophages as wild-type erythroblasts (13.9±0.5 erythroblasts per c-Maf+/+ macrophage and 
5.1±0.4 erythroblasts per c-Maf-/- macrophage; Figure 7C). These results demonstrate that the 
erythropoietic defects in c-Maf-/- embryos could be induced by an impaired hematopoietic 
microenvironment. Most likely, the suppressed functions of c-Maf-deficient central macrophages 
are responsible for the damaged erythroblastic islands.  
 
3-6. Identification of target genes of c-Maf in fetal liver macrophages. 
   To identify the molecular targets by which c-Maf regulates formation of erythroblastic islands in 
macrophages, we monitored expression of cell adhesion molecules by microarray analysis. The 
expression of several important adhesion molecules was decreased in c-Maf-/- macrophages (Table 
3). Expression of VCAM-1 was suppressed the furthest in these molecules. To confirm the results 
from microarray analysis, we performed quantitative RT-PCR analyses, examining expression 
levels of VCAM-1, Integrin alpha V, and Erythroblast Macrophage Protein (EMP). These three 
molecules are essential for erythroblastic islands formation, and are thus designated as 
Erythroblast-macrophage adhesive molecules.4 The Mac-1 positive cells from either E13.5 or E14.5 
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fetal liver were sorted by MACSTM and analyzed for mRNA abundance of these genes by real time 
RT-PCR analysis. Of note, we observed an approximately two-fold reduction in the VCAM-1 
mRNA expression level in the Mac-1 positive fraction from c-Maf-/- fetal liver, compared with the 
c-Maf+/+ control at E13.5 and E14.5 (Figure 8A-B). However, Integrin alpha V and EMP mRNA 
expression were not significantly different between c-Maf+/+ and c-Maf-/- (Figure 8A-B). Consistent 
with this observation, flow cytometry analysis of the fetal liver cells also verified a significant 
reduction of VCAM-1 positive cells in the c-Maf-/- fetal liver Mac-1 positive cells (20.1±4.0%: 
Figure 8C, right panel) compared to the c-Maf+/+ fetal liver Mac-1 positive cells (28.4±1.5%; Figure 
8C, left panel). 
   Given the significant suppression of VCAM-1 expression in c-Maf-/- fetal liver macrophages, we 
next addressed whether c-Maf could activate the VCAM-1 gene promoter. To this end, we 
performed a transfection assay in the RAW264.7 macrophage cell line, using the -0.7 kilobase (kb) 
VCAM-1 promoter region, which was joined to the 5’ end of the firefly luciferase reporter gene. 
Interestingly, the VCAM-1 promoter reporter was activated upon co-expression with the c-Maf 
expression plasmid (pEFX3-FLAG-c-Maf), in a c-Maf dose dependent manner (Figure 8D). 
Furthermore, sequence analysis using the TRANSFAC database identified two putative half MARE 
sites at 5’ -318bp and -136bp from the mouse VCAM-1 gene promoter. Overall, these data suggest 
that c-Maf may directly regulate the expression of VCAM-1 by binding the half-MARE site in its 
promoter region.  
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4. Discussion 
   Macrophages are important for hematopoiesis because they engulf nuclei of erythroblasts in 
erythroblastic islands, where the macrophages are surrounded by erythroblasts in the fetal liver, 
bone marrow and spleen.4 In the present study, we investigated deficiencies of the transcription 
factor c-Maf caused by embryonic anemia resulting from failure to form erythroblastic islands, as 
reflected by a defective adhesive function of fetal liver macrophages. Our main conclusion is that 
c-Maf is indispensable for the function of macrophages in erythropoiesis. 
   Our study clearly demonstrates that disruption of c-Maf causes impairment of erythroblastic 
islands formation due to dysfunction of fetal liver macrophages. In a methylcellulose culture system, 
c-Maf-/- hematopoietic stem/progenitor cells in fetal liver have a normal potential to differentiate 
into different lineages, and they can reconstitute the hematopoietic system of lethally irradiated 
mice. Because c-Maf is specifically expressed in macrophages within the fetal liver, it has been 
thought that c-Maf doesn’t regulate fetal liver erythropoiesis through a function of erythroblasts, but 
rather it performs an adhesive function of macrophages. There are several reports about genes that 
are related to the formation of erythroblastic islands, based on the knockout mice technique. 
Retinoblastoma deficient mice were analyzed for macrophage differentiation, and erythroblastic 
islands formation was reported to be impaired in these mice.7 The fetal livers of Dnase2a-/- mice 
contain many macrophages carrying undigested DNA, and interferon-β mRNA was expressed by 
the resident macrophages in the Dnase2a-/- fetal liver.36,37 In c-Maf-/- fetal livers, Retinoblastoma was 
comparably expressed in c-Maf+/+ and c-Maf-/- macrophages, therefore impaired erythroblastic 
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islands formation in c-Maf-/- mice is not related to Retinoblastoma (supplemental Figure 4). In 
addition, we could not detect the abnormal foci that are found in Dnase2a-/- fetal livers or the 
expression of interferon-β mRNA (Data not shown). Thus Retinoblastoma or DNase II do not cause 
the lethality of c-Maf-/- embryos.  
   To identify the target genes of c-Maf in fetal liver macrophages, we performed microarray 
analysis and found VCAM-1 was one of these target genes. VCAM-1 is known as an adhesion 
molecule expressed on macrophages of erythroblastic islands. Previous studies revealed that the 
formation of erythroblastic islands was impaired by the anti-VCAM-1 antibody.10,38 As shown in 
Figure 5, mRNA of VCAM-1 was decreased in c-Maf-/- fetal liver macrophages. This suggests that 
decreased expression of VCAM-1 may be at least in part responsible for impaired erythroblastic 
islands formation in c-Maf-/- fetal liver. The large Maf proteins are known to bind Maf recognition 
elements (MAREs) or the 5’ AT-rich half MARE. In the VCAM-1 promoter region, there is a 
half-MARE site 318bp and 136bp from the transcription start site, so c-Maf may directly regulate 
VCAM-1 expression in fetal liver macrophages. Recently, Kohyama et al. revealed that Spi-C 
controls the development of red pulp macrophages required for red blood cell recycling, and it 
regulates VCAM-1 expression in red pulp macrophages.39 These earlier results and ours suggest that 
the regulation of VCAM-1 expression by transcription factors strongly affects the function of tissue 
macrophages. We previously reported that c-Maf regulates F4/80 expression30, and in the present 
study we demonstrate that c-Maf regulates VCAM-1 expression. In macrophages, c-Maf regulates 
the expression of cell surface molecules that are involved in macrophage function.  
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   We found that c-Maf is indispensable for erythroblastic island formation in the embryonic stage, 
but this was not the case for the adult stage. In a reconstitution assay using fetal liver cells, c-Maf-/- 
hematopoietic cells reconstituted hematopoiesis of lethally irradiated mice, and the mice that were 
transplanted with c-Maf-/- fetal liver cells did not show anemia. These results indicate that the 
importance of erythroblastic islands is not the same in the embryonic versus adult stage. This 
hypothesis is supported by previous observations. In Palld -/- fetal liver, erythroblastic islands 
formation was impaired, but Palld-/- fetal liver cells could reconstitute the blood of lethally 
irradiated mice.8 Thus, c-Maf and Palladin are important for hematopoiesis only in the embryonic 
stage. On the other hand, a previous study found that ICAM-4 is critical in erythroblastic islands 
formation in adult marrow, but ICAM-4 knockout mice did not show anemia in the embryonic stage. 
This result indicates that ICAM-4 is important for hematopoiesis only in the adult stage.40 Overall, 
the data indicate that there might be different mechanisms between fetal liver and adult 
marrow/spleen erythroblastic islands formation.  
   Recent reports have indicated that definitive as well as primitive erythropoiesis are related to 
erythroblastic islands.38 Kingsley et al. revealed that yolk sac-derived primitive erythroblasts 
enucleate during gestation41 and Isern et al. also demonstrated, using transgenic mouse lines, that 
primitive erythroblasts enucleate within the fetal liver.38,42 Our quantitative RT-PCR results 
suggested that definitive erythropoiesis is more involved in erythroblastic islands formation than is 
primitive erythropoiesis in vivo (Figure 4). Therefore, this result indicates that definitive 
erythropoiesis in fetal liver is predominantly impaired in c-Maf-/- embryos, whereas primitive 
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erythropoiesis is maintained in c-Maf-/- embryos.  
   Our study demonstrated that c-Maf-/- mice were embryonic lethal on the C57BL/6 background 
and that c-Maf-/- macrophages were responsible for this. Previous reports from our laboratory and 
from others indicated that c-Maf-/- mice were lethal around birth on C57BL/6Jx129/SV or BALB/c 
backgrounds.16,43,44 It is known that the cytokine production in T helper cells differs between 
C57BL/6 and BALB/c backgrounds. Recently Mills at al. reported that cytokine production in 
macrophages differed according to the backgrounds of the mice.45 On a C57BL/6 background, 
inflammatory cytokine production is more dominant than on a BALB/c background. Therefore our 
c-Maf-/- mice were lethal at an earlier gestational date than indicated by previous reports. We found 
that c-Maf-/- fetal liver macrophages produced more cytokines than c-Maf+/+ fetal liver macrophages 
(Figure 9). This finding supports the idea that the c-Maf-/- macrophages are responsible for anemia 
and lethality. This hypothesis may also explain the phenotype discrepancy between c-Maf-/- mice 
and F4/80-/- or VCAM-1-/- mice. Neither F4/80 knockout mice nor mice with a conditional ablation 
of VCAM-1 in blood cells are embryonic lethal.46-48 Our results indicate that increased apoptotic red 
blood cells in c-Maf-/- fetal liver is thought to be trigger inflammatory cytokine production, and 
these cytokines may induce a secondary cause of embryonic lethality on the C57BL/6 background. 
   In summary, we have shown that the transcription factor c-Maf gene affects the hematopoietic 
microenvironment by playing a crucial role in fetal liver macrophages.  
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7. Tables 
Table 1. Genotypic analysis of neonates and embryos from c-Maf +/- intercross on a C57BL/6J back 
ground.  
Number of each c-Maf genotype Embryonic stage 
c-Maf +/+ c-Maf +/- c-Maf -/- 
Total numbers of embryos 
E12.5 12 20 10  42 
E13.5* 20 35 16 (3) 71 
E14.5* 42 47 30 (7) 119 
E15.5* 16 40 15 (2) 71 
E16.5* 11 15 4 (3) 30 
E18.5* 9 12 3 (2) 24 
Neonate 13 29 0 42 
Embryos were isolated at the indicated time points of gestation and within 7 days of birth 
(postnatal), and analyzed for viability. Genotypes of embryos were determined by PCR. 
*Parentheses indicate number of dead embryos. 
 
Table 2. Blood cell counts 10-12 weeks after fetal liver cell transplantation in mice. 
Genotype of transplanted FLC c-Maf +/+ c-Maf -/- p value 
WBC, /ml 18,200±1,880 17,800±1,240 NS 
RBC, x104/ ml 968±7.5 944±8.1 p =0.04 
Hb, g/dl 14.9±0.5 13.8±0.1 p =0.04 
HCT, % 46.6±0.5 45.5±0.3 NS 
MCV, fl 48.1±0.3 48.2±0.3 NS 
MCH, pg 15.4±0.5 14.6±0.1 NS 
PLT, x104/ ml 111.6±4.2 99.6±3.6 p =0.04 
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Values shown are the mean ± SEM (Standard Error of the Mean) for 12 mice per genotype. FLC, 
fetal liver cell; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; HCT, hematocrit; 
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; PLT, platelet; NS, not 
significant.  
 
Table 3. Expression of genes involved in macrophage signature 
Symbol Official Full Name 
c-Maf +/+ 
Signal 
c-Maf -/- 
Signal 'Fold' 
VCAM-1 vascular cell adhesion molecule 1 8.3 1.6 0.19  
Mrc1 mannose receptor, C type 1 19.8 5.7 0.29  
Csf1r colony stimulating factor 1 receptor 45 16.8 0.37  
Sell selectin, lymphocyte 26.7 10 0.37  
Lamp2 lysosomal-associated membrane protein 2 8.9 3.3 0.37  
Itgav Integrin alpha V 1.2 0.5 0.41 
Maea (EMP) macrophage erythroblast attacher 26.2 14.5 0.55 
Emr1 (F4/80) 
 
EGF-like module containing, mucin-like,  
hormone receptor-like sequence 1 71.4 48.1 0.67  
Itgam (Mac-1)  integrin alpha M 5.8 3.9 0.67  
Cd163 CD163 antigen 0.6 0.4 0.67  
Cd14 CD14 antigen 11.8 9.4 0.80  
Fcgr1 Fc receptor, IgG, high affinity I 15.7 17.6 1.12  
Fetal liver macrophages were purified by flow cytometry from c-Maf +/+ or c-Maf -/- fetal livers. The 
‘fold change’ in the gene expression was determined by dividing the signal obtained with c-Maf -/- 
fetal liver macrophage RNA by the signal obtained with c-Maf +/+ RNA.  
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8. Figure Legends 
Figure 1. c-Maf-/- embryos show anemia. 
(A) Gross appearance of E13.5 embryos. The c-Maf-/- embryo is paler and smaller than its c-Maf+/+ 
littermate. Scale bar represents 5mm. (B) Hematocrit values for c-Maf+/+ (n=6) and c-Maf-/- (n=6) at 
E13.5 embryos, c-Maf+/+ (n=8) and c-Maf-/- (n=7) at E14.5 embryos, c-Maf+/+ (n=12) and c-Maf-/- 
(n=9) at E15.5 embryos. Data are presented as mean ±SEM. The mean hematocrit values for 
c-Maf-/- embryos were significantly lower than those for c-Maf+/+ at E13.5, E14.5 and E15.5. (C) 
Blood smears from E13.5 embryos stained with May-Grünwald-Giemsa stain. The blood smear 
from a c-Maf-/- embryo contains far fewer enucleated red blood cells. Scale bars represent 20µm. 
(D) The percentage of enucleated red blood cells in peripheral blood for c-Maf+/+ (n=5) and c-Maf-/- 
(n=7) at E13.5 embryos, c-Maf+/+ (n=4) and c-Maf-/- (n=4) at E14.5 embryos, c-Maf+/+ (n=8) and 
c-Maf-/- (n=8) at E15.5 embryos. Data are presented as mean ±SEM. The percentage of enucleated 
red blood cells is significantly reduced in c-Maf-/- embryos as compared with c-Maf+/+ embryos at 
E13.5, E14.5 and E15.5. *p< 0.05, **p< 0.01. 
 
Figure 2. Increased number of apoptotic cells is observed in c-Maf-/- fetal liver. 
(A) Gross appearance of E13.5 fetal liver. The c-Maf-/- fetal liver is smaller than a wild-type fetal 
liver. Scale bar represents 100µm. (B) the mean total number of fetal liver cells in c-Maf+/+ (n=14) 
and c-Maf-/- (n=10) at E13.5 embryos, c-Maf+/+ (n=6) and c-Maf-/- (n=4) at E14.5 embryos, c-Maf+/+ 
(n=8) and c-Maf-/- (n=8) at E15.5 embryos,. The mean number of fetal liver cells is significantly 
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reduced in c-Maf-/- embryos. Data are presented as mean ±SEM. (C) Hematoxin and Eosin staining 
of c-Maf+/- and c-Maf-/- fetal liver sections (Upper panel). TUNEL assay shows increased apoptosis 
in c-Maf-/- fetal liver (middle and lower panel). Scale bars in upper and middle panel represent 
200µm. Scale bars in lower panel represent 50µm. (D) The fraction of cells in different phases of 
the cell cycle was measured by propidium iodide (PI) staining followed by flow cytometric analyses. 
Typical flow cytometric profiles of c-Maf+/+ and c-Maf-/- fetal liver cells isolated from E12.5 
embryos are shown. The percentage of cells in sub-G1, G1, S phase, and G2/M are indicated. The 
sub-G1 represents the apoptotic population. The apoptotic population was increased in c-Maf-/- fetal 
liver. □ represents c-Maf+/+ ; ■ represents c-Maf-/-. n = 3 per group; *p<0.05. Data are presented as 
mean ±SEM. 
 
Figure 3. Definitive erythropoiesis in fetal liver is impaired in c-Maf-/- embryos but c-Maf-/- 
fetal liver cells can form erythroid colonies. 
 (A) Typical flow cytometric profiles of c-Maf+/+ and c-Maf-/- fetal liver cells isolated from E13.5 
embryos double labeled with a FITC-conjugated anti-CD71 monoclonal antibody (mAb) and a 
APC-conjugated anti-TER-119 mAb. Regions R1 to R5 are defined by a characteristic staining 
pattern of cells as indicated. The mean percentages for the populations in each region are shown in 
red. (B) Comparison of c-Maf+/+ and c-Maf-/- fetal livers in the ratio of R1 to R5. □ represents 
c-Maf+/+ ; ■ represents c-Maf-/-. n = 5~7 per group; *p<0.05. (C) The ratio of annexin V positive 
cells from R1 to R5 was compared in c-Maf+/+ and c-Maf-/- fetal livers. □ represents c-Maf+/+ ; ■ 
 34 
represents c-Maf-/-. n = 5~7 per group; *p<0.05. (D) Cytospin preparation from c-Maf+/+ and c-Maf-/- 
fetal liver single cells stained with May-Grünwald Giemsa. Mature red blood cells (R4 to R5) were 
reduced in c-Maf-/- fetal liver as compared with c-Maf+/+ fetal liver. Arrows indicate R4 and R5 
population. (E) In vitro colony assay using fetal liver cells from c-Maf+/+ (□) and c-Maf-/- (■) 
embryos. A total of 20, 000 fetal liver cells were plated and cultured with methylcellulose media. 
The numbers of CFU-E, BFU-E and CFU-GEMM derived colonies are shown. The number of 
CFU-E derived colonies was significantly increased in c-Maf-/- embryos. There was no significant 
difference between the number of BFU-E and CFU-GEMM derived colonies in c-Maf+/+ (□) and 
c-Maf-/- (■) embryos. n = 6~7 per group; *p<0.05. Data are presented as mean ±SEM. CFU-E: 
Colony-forming unit-erythroid, BFU-E: Burst-forming unit-erythroid, CFU-GEMM: 
Colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte,  
 
Figure 4. Decreased mRNA expression of βmajor/βminor globins in c-Maf-/- fetal liver. 
Mac-1 negative fraction was isolated by Mac-1 magnetic beads. Analyses of mRNA expression of 
mouse β-globin chains showed that mRNA expression of βmajor/βminor globins was decreased, 
whereas embryonic β-globin genes (εy-globin and βh1-globin) are maintained in Mac-1 negative 
fraction in E13.5 c-Maf-/- fetal liver cells. □ represents c-Maf+/+; ■ represents c-Maf-/-. n=7 per group. 
*p<0.01. Data are presented as mean ±SEM. 
 
Figure 5. The in vitro erythroid colony formation of c-Maf-/- fetal liver cells is not impaired. 
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(A) Hemoglobin levels in day 2 CFU-Es from c-Maf+/+ and c-Maf-/- E13.5 fetal liver cells are shown. 
(B) Cytospun cells from day 2 CFU-Es (from E13.5 fetal liver cells in c-Maf+/+ upper panel, and 
c-Maf-/-; lower panel) are stained with May-Grünwald Giemsa. Note enucleated red blood cells are 
observed in cytospin picked from c-Maf-/- CFU-Es. The scale bar represents 20µm.  
 
Figure 6. c-Maf-/- fetal liver cells can reconstitute adult hematopoiesis in lethally irradiated 
mice. 
(A) 2 ×106  E14.5 fetal liver cells from c-Maf+/+ or c-Maf-/- embryos were injected into lethally 
irradiated recipient mice. After 8-10 weeks following transplantation, the donor leukocyte 
chimerism of the mice reconstituted with c-Maf-/- fetal liver cells was comparable with that of the 
mice reconstituted with c-Maf+/+ fetal liver cells. The reconstitution efficiency was checked with the 
Ly5.2/Ly5.2 ratio of peripheral blood cells by flow cytometry. Donor chimerism was determined to 
be: [ %Ly5.1+ / %Ly5.1+ + %Ly5.2+ ] × 100. (B) No significant difference was found in the 
proportion of each lineage in peripheral blood between c-Maf+/+ fetal liver cells-transplanted mice 
and c-Maf-/- fetal liver cells-transplanted mice. (C and D) Left: Flow cytometric analyses of the 
expression of TER-119 and CD71 in total bone marrow cells prepared from femur of c-Maf+/+ fetal 
liver cells transplanted (left panels) and c-Maf-/- fetal liver cells transplanted (center panels) mice. 
Frequencies (%) of cells in gated fractions (squared) are shown. In the right panels, frequencies (%) 
of CD71+/TER-119- (top left region: Q1), CD71+/TER-119+ (top right region: Q2) and 
CD71-/TER-119+ (bottom right region: Q3) cells in bone marrow are also indicated. Right: 
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Frequencies (%) of CD71/TER-119 cells (gated fractions of the left panels). □ represents c-Maf+/+ 
fetal liver cells transplanted mice; ■ represents c-Maf-/- fetal liver cells transplanted mice. n=4 per 
group. (D) Left: Flow cytometric analyses of the expression of TER-119 and CD71 in total spleen 
cells prepared from c-Maf+/+ fetal liver cells transplanted mice (left panels) and c-Maf-/- fetal liver 
cells transplanted mice (center panels). In the right panels, the frequencies (%) of CD71+ (top left 
and top right region: CD71+) and CD71-/TER-119+ ( indicated squared gate in bottom right region: 
TER-119+) cells in spleen are also indicated. □ represents c-Maf+/+ fetal liver cells transplanted 
mice; ■ represents c-Maf-/- fetal liver cells transplanted mice. n=4 per group. FLC, fetal liver cell; 
 
Figure 7. Absence of c-Maf impairs the formation of erythroblastic islands in the fetal liver. 
(A) Native erythroblastic islands isolated from c-Maf+/+ and c-Maf-/- fetal liver were immunostained 
with F4/80 (Green) and TER-119 (Red) antibodies as described in Material and methods. F4/80 is 
used as a macrophage-specific marker, and Ter119 is used as a marker for erythroblasts. The 
number of erythroblasts surrounding each macrophage was significantly reduced in c-Maf-/- fetal 
liver. (B) Erythroblastic islands reconstituted with c-Maf+/+ erythroblasts were immunostained with 
F4/80 (Green) and TER119 (Red) antibodies. The number of c-Maf+/+ erythroblasts surrounding 
each c-Maf-/- macrophage was significantly reduced as compared with that seen for c-Maf+/+ 
macrophages. (C) Erythroblastic islands reconstituted with c-Maf-/- erythroblasts were 
immunostained with F4/80 (Green) and TER119 (Red) antibodies. The number of c-Maf-/- 
erythroblasts surrounding each c-Maf-/- macrophage was significantly reduced compared with that 
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seen for c-Maf+/+ macrophages. c-Maf-/- erythroblasts can form reconstituted erythroblastic islands 
with c-Maf+/+ macrophage. However, c-Maf-/- macrophages showed impaired formation of 
reconstituted erythroblastic islands. The scale bar represents 20µm. n = 4~6 embryos per group. For 
each combination, at least 20 macrophages per embryo were analyzed. *p<0.05. Data are presented 
as mean ±SEM. 
 
Figure 8. Decreased expression of VCAM-1 in c-Maf-/- fetal liver macrophage . 
 mRNA expression profiles of “Erythroblast-macrophage adhesive interaction” genes at E13.5(A) 
and at E14.5 (B). Total RNA obtained from Mac-1 positive fraction (gray bar) and Mac-1 negative 
fraction (open bar) of fetal liver cells was used for analyses. VCAM-1 expression was decreased in 
c-Maf-/- macrophages at E13.5 and E14.5. n = 7 per group; *p<0.05. All of the data are presented as 
mean ±SEM. (C) Representative histograms plotted after gating on Mac-1(CD11b) positive fraction 
from E13.5 fetal liver cells double labeled with a FITC-conjugated anti-Mac1(CD11b) mAb and a 
biotinylated anti-VCAM-1 mAb with APC conjugated streptavidin. c-Maf-/- fetal liver macrophages 
expressed a suppressed level of VCAM-1 compared with c-Maf+/+ littermate controls. The bar graph 
shows that the percentage of VCAM-1 positive cells is decreased in c-Maf-/- fetal liver. (D) 
Schematic diagram of a luciferase reporter construct using a VCAM-1-0.7 kb promoter 
(VCAM-1-Luc) ligated to a firefly luciferase cassette. Two putative half MARE sites (5’ -318bp 
and -136bp) are indicated. The pEFX3-FLAG-cMaf (10 ng or 40 ng per well) expression vectors 
were co-transfected with the reporter plasmid into the macrophage cell line RAW264.7. The relative 
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luciferase activity shown is derived from averages of 2 independent experiments (as mean ±SEM). 
The luciferase activity seen in RAW264.7 cells transfected with the reporter plasmid and with an 
empty vector was normalized to a value of 1 as the standard (*p<0.05).  
 
Figure 9. c-Maf-/- fetal liver macrophage mRNA expression profiles 
 mRNA expression profiles of Rb and inflammatory cytokines. The population enriched for the 
Mac1-negative cells (open bar) and Mac1-positive cells (gray bar). n=7 per group. *p<0.05. Data 
are presented as mean ±SEM. 
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